0001437749-24-003153.txt : 20240205
0001437749-24-003153.hdr.sgml : 20240205
20240205211514
ACCESSION NUMBER: 0001437749-24-003153
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schoenberg Mark
CENTRAL INDEX KEY: 0001763581
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24597832
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA TA ASIYA STREET
CITY: RA ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4/A
1
rdgdoc.xml
FORM 4/A
X0508
4/A
2024-01-31
2024-02-02
0001668243
UroGen Pharma Ltd.
URGN
0001763581
Schoenberg Mark
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Medical Officer
0
Ordinary Shares
2024-02-01
4
S
0
1137
15.78
D
149423
D
Ordinary Shares
2024-02-01
4
S
0
758
15.78
D
149998
D
Ordinary Shares
2024-02-01
4
S
0
1894
15.78
D
151437
D
This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.
/s/ Jason D. Smith, Attorney-in-Fact
2024-02-05